By Ransdell Pierson and Bill Berkrot NEW YORK (Reuters) - Pfizer Inc's top officials said on Monday they are weighing all strategies, including potential hostile maneuvers, in the company's effort to seal a $106 billion takeover of British drugmaker AstraZeneca Plc. "Any option you can think of would be an option," Pfizer Chief Financial Officer Frank D'Amelio said in a telephone interview, when asked whether Pfizer might take its case directly to AstraZeneca shareholders before a May 26 deadline. That is the date by which British takeover law requires Pfizer to either make a bid for the London-based rival or walk away, unless both companies agree to seek an extension of the deadline. "What we really need is to have AstraZeneca engage with us," D'Amelio said.
via Health News Headlines - Yahoo News
Read More Here.. 
Lake forest health and fitness http://ift.tt/Su9wMO
No comments:
Post a Comment